Discrepant and often contradictory results have accumulated regarding the antidepressant and pro-cognitive effects of serotonin transporter (SERT) antagonists in Alzheimer’s disease. The gene discussed is SLC6A4; the disease is early-onset autosomal dominant Alzheimer disease.